Search

Wilms tumour in children

Wilms tumours are the most common type of kidney (renal) cancer in children. About 90 children in the UK are diagnosed with a Wilms tumour each year. It most often affects children under the age of seven.

Germ cell tumours in children

Approximately 50 children in the UK develop malignant germ cell tumours each year. Most children who develop germ cell tumours will be cured.

Retinoblastoma

Retinoblastoma is cancer of the retina, the light sensitive lining of the eye. It usually affects children under five and about 40 to 50 cases are diagnosed in the UK each year. Treatment is very effective and nearly all (98 out of 100) children with retinoblastoma are cured.

Liver tumours in children

Approximately 20 children in the UK develop primary liver tumours each year. Boys are affected more commonly than girls. Liver tumours can be non-cancerous (benign) or cancerous (malignant). This information is about malignant liver tumours.

Langerhans Cell Histiocytosis (LCH) in children

This information is about a condition called Langerhans Cell Histiocytosis (LCH) in children. About 50 children in the UK develop LCH each year. It can affect children of any age, and is more common in boys than in girls.

Rare cancers in children

Childhood cancers are not common, but there are a number of very rare types. Rare cancers in children make up fewer than 1 in 30 of all childhood cancers

Practical issues

When your child finishes treatment, they will be seen frequently in clinic. How often will depend on the needs of your child, but it is usually every 4-6 weeks during the first year.

Feelings and emotions

Most parents whose child is approaching the end of treatment feel relieved that the treatment has worked, and that it no longer needs to play a big part in the life of their family. Families can stop planning around treatment and start to look forward.

Moving on

Moving on after your child has finished treatment

What happens now?

Once active treatment finishes, your child will move onto a specialised follow-up pathway designed to support them throughout their life.